Beyond SBIRs: Non-Dilutive Funding Strategies to Advance Your Pipeline and Bottom-Line 

7 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Are you seeking innovative ways to fund your biotech venture without giving away equity or navigating lengthy grant submissions? The Beyond SBIRs: Non-Dilutive Funding Strategies to Advance Your Pipeline and Bottom-Line panel at RESI JPM offers an engaging exploration of non-dilutive funding opportunities through partnerships with federal agencies and labs.

This interactive panel, hosted by the National Institute of Health, will explore how federal labs provide indirect or in-kind support, investing resources, expertise, and capabilities to advance your R&D efforts. The discussion will showcase how companies across various development stages can benefit, from achieving key value inflection points to minimizing financial burn rates through strategic partnerships. Attendees will gain insights into the practical applications of these partnerships and learn how to optimize their impact on company growth.

Each year, agencies like the NIH partner with healthcare companies globally, offering essential resources to advance technology development and commercialization. This panel will provide valuable perspectives on strategy, lessons learned, and best practices for leveraging these opportunities effectively.

Meet the Panelists:


Michael Salgaller

Supervisor Specialist
NIH Technology Transfer Office
(Moderator)

Deborah Birx

Senior Fellow
George W. Bush Institute, and Former White House Coronavirus Response Coordinator

Vlad Popov

CIO, Frederick National Lab for Cancer Research & Regional Director
Federal Lab Consortium

Jill Hopkins

CMO and President of R&D
Aura Biosciences

Erica Stone

VP Oncology
Gigagen

Xiaoxi (Sophie) Wei, PhD

CEO & Co-Founder
X-Therma Inc.

Why Attend?

This session provides a rare opportunity to engage directly with experts who have successfully navigated non-dilutive funding pathways. Whether you’re exploring partnerships with federal labs or seeking to enhance your funding strategy, this panel will equip you with the tools and insights needed to drive your pipeline forward.

Don’t miss this opportunity to learn from industry leaders and federal representatives at RESI JPM 2025!

RESI-JPM-2025-1100PX

Register-now-button-new

Leave a comment